These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 10980058

  • 1. Targeted prophylaxis with amphotericin B lipid complex in liver transplantation.
    Singhal S, Ellis RW, Jones SG, Miller SJ, Fisher NC, Hastings JG, Mutimer DJ.
    Liver Transpl; 2000 Sep; 6(5):588-95. PubMed ID: 10980058
    [Abstract] [Full Text] [Related]

  • 2. Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Alexander BD, Dodds Ashley ES, Addison RM, Alspaugh JA, Chao NJ, Perfect JR.
    Transpl Infect Dis; 2006 Mar; 8(1):13-20. PubMed ID: 16623816
    [Abstract] [Full Text] [Related]

  • 3. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
    Castroagudín JF, Pontón C, Bustamante M, Otero E, Martínez J, Tomé S, Conde R, Segade FR, Delgado M, Brage A, Galbán C, Varo E.
    Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
    [Abstract] [Full Text] [Related]

  • 4. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation.
    Shah T, Lai WK, Gow P, Leeming J, Mutimer D.
    Transpl Infect Dis; 2005 Nov; 7(3-4):126-32. PubMed ID: 16390401
    [Abstract] [Full Text] [Related]

  • 5. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
    Borro JM, Solé A, de la Torre M, Pastor A, Fernandez R, Saura A, Delgado M, Monte E, Gonzalez D.
    Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
    Wingard JR.
    Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244
    [Abstract] [Full Text] [Related]

  • 7. Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain.
    Aguado JM, Lumbreras C, González-Vidal D, Grupo de Farmacovigilancia de Abelcet.
    Clin Microbiol Infect; 2004 Sep; 10(9):785-90. PubMed ID: 15355408
    [Abstract] [Full Text] [Related]

  • 8. Delayed ABLC prophylaxis after allogeneic stem-cell transplantation.
    Jansen J, Akard LP, Wack MF, Thompson JM, Dugan MJ, Leslie JK, Mattison R.
    Mycoses; 2006 Sep; 49(5):397-404. PubMed ID: 16922792
    [Abstract] [Full Text] [Related]

  • 9. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP, Kurup A, Goh YT, Fook-Chong SM, Tan PH.
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [Abstract] [Full Text] [Related]

  • 10. Controlled trials of amphotericin B lipid complex and other lipid-associated formulations.
    Winston DJ, Schiller GJ.
    Clin Infect Dis; 2000 Jan; 30(1):236-7. PubMed ID: 10619780
    [No Abstract] [Full Text] [Related]

  • 11. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients.
    Fortún J, Martín-Davila P, Moreno S, Barcena R, de Vicente E, Honrubia A, García M, Nuño J, Candela A, Uriarte M, Pintado V.
    J Antimicrob Chemother; 2003 Nov; 52(5):813-9. PubMed ID: 14563893
    [Abstract] [Full Text] [Related]

  • 12. Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.
    Drew RH, Dodds Ashley E, Benjamin DK, Duane Davis R, Palmer SM, Perfect JR.
    Transplantation; 2004 Jan 27; 77(2):232-7. PubMed ID: 14742987
    [Abstract] [Full Text] [Related]

  • 13. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
    Kern W, Behre G, Rudolf T, Kerkhoff A, Grote-Metke A, Eimermacher H, Kubica U, Wörmann B, Büchner T, Hiddemann W.
    Cancer; 1998 Jul 15; 83(2):291-301. PubMed ID: 9669812
    [Abstract] [Full Text] [Related]

  • 14. Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.
    López-Vélez R, Videla S, Márquez M, Boix V, Jiménez-Mejías ME, Górgolas M, Arribas JR, Salas A, Laguna F, Sust M, Cañavate C, Alvar J, Spanish HIV-Leishmania Study Group.
    J Antimicrob Chemother; 2004 Mar 15; 53(3):540-3. PubMed ID: 14739148
    [Abstract] [Full Text] [Related]

  • 15. Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient.
    Crompton JA, Alexander D, Somerville T, Shihab FS.
    Transpl Infect Dis; 2004 Dec 15; 6(4):183-7. PubMed ID: 15762937
    [Abstract] [Full Text] [Related]

  • 16. [Invasive fungal infections in liver transplant recipients: analysis of 21 cases].
    Miguélez M, Lumbreras C, Herrero JA, Aguado JM, del Palacio A, Colina F, Gómez R, Lizasoain M, Moreno E, Rodríguez-Noriega A.
    Med Clin (Barc); 1998 Mar 28; 110(11):406-10. PubMed ID: 9608495
    [Abstract] [Full Text] [Related]

  • 17. Amphotericin B lipid complex (ABLC)-associated hypertension: case report and review.
    Rowles DM, Fraser SL.
    Clin Infect Dis; 1999 Dec 28; 29(6):1564-5. PubMed ID: 10585814
    [Abstract] [Full Text] [Related]

  • 18. Use of an amphotericin B lipid complex for treatment of blastomycosis in dogs.
    Krawiec DR, McKiernan BC, Twardock AR, Swenson CE, Itkin RJ, Johnson LR, Kurowsky LK, Marks CA.
    J Am Vet Med Assoc; 1996 Dec 15; 209(12):2073-5. PubMed ID: 8960189
    [Abstract] [Full Text] [Related]

  • 19. Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients.
    Saliba F, Delvart V, Ichaï P, Kassis N, Botterel F, Mihaila L, Azoulay D, Adam R, Castaing D, Bretagne S, Samuel D.
    Med Mycol; 2013 Feb 15; 51(2):155-63. PubMed ID: 22800082
    [Abstract] [Full Text] [Related]

  • 20. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
    Hachem RY, Boktour MR, Hanna HA, Husni RN, Torres HA, Afif C, Kontoyiannis DP, Raad II.
    Cancer; 2008 Mar 15; 112(6):1282-7. PubMed ID: 18224662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.